Spots Global Cancer Trial Database for stem cell mobilization
Every month we try and update this database with for stem cell mobilization cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD) | NCT00444912 | Non-Hodgkin Lym... Hodgkin Disease | G-CSF plus pler... G-CSF plus pler... rituximab | 18 Years - 70 Years | Sanofi | |
| AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease | NCT00396201 | Hodgkin's Disea... | G-CSF Plus Pler... | 18 Years - 70 Years | Sanofi | |
| Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation | NCT00396383 | Multiple Myelom... | plerixafor | 18 Years - 75 Years | Sanofi | |
| Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5) | NCT00751894 | Solid Malignanc... | Pegfilgrastim (... | - 18 Years | University Hospital, Clermont-Ferrand | |
| Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients | NCT00322387 | Lymphoma, Non-H... Multiple Myelom... | G-CSF and pleri... | 18 Years - 70 Years | Sanofi | |
| Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma | NCT00306111 | Non-Hodgkin Lym... | pegfilgrastim | 18 Years - | University Hospital Tuebingen | |
| TevaGastrim for Stem Cell Mobilization Sibling Donors | NCT01542944 | Acute Myeloid L... Myelodysplastic... | TevaGastrim | 18 Years - 70 Years | Sheba Medical Center | |
| Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia | NCT00906945 | Leukemia, Myelo... | G-CSF Plerixafor Mitoxantrone Etoposide Cytarabine | 18 Years - 70 Years | Washington University School of Medicine | |
| Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | NCT00299780 | Lymphoma Multiple Myelom... Acute Myelogeno... | Stem cell mobil... | 18 Years - 75 Years | Massachusetts General Hospital | |
| AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease | NCT00396201 | Hodgkin's Disea... | G-CSF Plus Pler... | 18 Years - 70 Years | Sanofi | |
| ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells | NCT00400556 | Multiple Myelom... Cutaneous Lymph... | ATRA plus G-CSF... | 18 Years - 70 Years | Peter MacCallum Cancer Centre, Australia | |
| Lonquek for Autologous Stem Cell Mobilization | NCT02488382 | Lymphoma Multiple Myelom... | Lonquek | 18 Years - 65 Years | Sheba Medical Center | |
| AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease | NCT00396201 | Hodgkin's Disea... | G-CSF Plus Pler... | 18 Years - 70 Years | Sanofi | |
| Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients | NCT00322387 | Lymphoma, Non-H... Multiple Myelom... | G-CSF and pleri... | 18 Years - 70 Years | Sanofi | |
| AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone | NCT00395967 | Multiple Myelom... Lymphoma, Non-H... | G-CSF plus pler... | 18 Years - 75 Years | Sanofi | |
| Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | NCT00948922 | Multiple Myelom... | Bortezomib Melphalan Autologous Stem... Fludarabine Allogeneic Stem... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | NCT00948922 | Multiple Myelom... | Bortezomib Melphalan Autologous Stem... Fludarabine Allogeneic Stem... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| TevaGastrim for Stem Cell Mobilization Sibling Donors | NCT01542944 | Acute Myeloid L... Myelodysplastic... | TevaGastrim | 18 Years - 70 Years | Sheba Medical Center | |
| Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | NCT00948922 | Multiple Myelom... | Bortezomib Melphalan Autologous Stem... Fludarabine Allogeneic Stem... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients | NCT00322491 | Lymphoma, Non-H... Multiple Myelom... | G-CSF Plus Pler... | 18 Years - 70 Years | Sanofi | |
| Non-interventional Study on Salvage Auto in Relapsed Myeloma | NCT02439476 | Relapsed Multip... | 18 Years - 75 Years | Association for Training, Education, and Research in Hematology, Immunology, and Transplantation | ||
| Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients | NCT00322842 | Lymphoma, Non-H... Multiple Myelom... | G-CSF Plus Pler... | 18 Years - 70 Years | Sanofi | |
| AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF | NCT00396266 | Multiple Myelom... Lymphoma, Non-H... | G-CSF Plus Pler... | 18 Years - 70 Years | Sanofi | |
| Mozobil for Autologous Stem Cell Mobilization | NCT01164345 | Non-Hodgkin's L... Hodgkin's Lymph... Stem Cell Mobil... Autologous Stem... | Plerixafor | 18 Years - 75 Years | Sheba Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
